Wakamoto Pharmaceutical Co.,Ltd.

TSE:4512.T

245 (JPY) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

20232022202120202019201820172016201520142013201220112010200920082007
Operating Activities:
Net Income 108.959211.574284.858-703.007-911.042-229.799174.169169.988126.045231.6681,358.773448.59-127.486-626.824140.998607.372717.259
Depreciation & Amortization 345.455445.752470.083484.314465.236468.266527.053659.374746.445766.985706.932787.4731,008.2611,204.576720.099553.412512.271
Deferred Income Tax 00000000000000000
Stock Based Compensation 00000000000000000
Change In Working Capital -259.265-221.245-68.57455.029639.127-353.401-79.88521.033-300.475-125.027345.708109.677-186.703-204.202-84.427-98.216452.713
Accounts Receivables 381.887-532.097-63.942477.795564.326-151.673-188.563191.125199.7040000.3920000
Inventory -53.158298.133-292.126504.99510.193-360.057348.234185.998-261.244-294.493188.89433.369-105.773-533.364110.948-237.641-70.853
Accounts Payables -185.636-112.694299.667-522.81417.791261.775-86.636127.101-139.17100000000
Other Working Capital -402.358125.413-12.169-4.94746.817-103.446-428.114335.035-39.231169.466156.81476.308-80.93329.162-195.375139.425523.566
Other Non Cash Items 245.33195.839-347.197-72.898-348.3850.441-65.636-252.1122.288301.676-782.241-145.85-104.816-27.037-287.28-237.986-788.072
Operating Cash Flow -107.338631.92339.174163.438-155.064-114.493555.7061,098.285594.3031,175.3021,629.1721,199.89589.256346.513489.39824.582894.171
Investing Activities:
Investments In Property Plant And Equipment -555.686-211.163-368.141-482.255-207.26-596.321-426.044-348.538-482.62-1,240.441-736.735-547.001-726.648-477.731-2,627.359-1,826.93-658.042
Acquisitions Net 0-125.856-130.629-123.573-68.77554.949105.973281.62-67.025-31.41136.50900-10.1730-1-12.714
Purchases Of Investments -41.781-22.876-3.069-2.921-2.848-2.791-56.409-117.832-122.751-120.295-319.011-5.63-2.98-2.838-2.767-108.867-544.353
Sales Maturities Of Investments 578.077251.172421.784285.66431.397113.388435.117192.845274.95290.501113.67700101.65
Other Investing Activites 17.04125.854130.627123.57268.774225.305-105.97113.83868.30531.41-35.987621.826224.527173.092-24.0821,745.877-461.919
Investing Cash Flow -2.35217.13150.572-199.513-178.712-205.47-47.33421.933-329.139-1,270.236-941.54769.195-505.101-316.65-2,654.208-189.32-1,672.028
Financing Activities:
Debt Repayment -1.059-1.059-1.059-3.233-40-160-160-328-208-1,006-232-196-196-174000
Common Stock Issued 0.0111.0591.0593.233-3.6910.0710.0260.6470.1630.8250.0970.9010.808118.51200838
Common Stock Repurchased -0.036-0.075-0.062-0.084-0.066-0.109-3.616-3.05-3.392-5.52-6.409-3.629-4.353-8.084-17.674-14.557-14.449
Dividends Paid -103.901-0.48-0.498-0.511-0.612-103.56-103.718-103.674-103.698-103.71-0.923-0.897-2.457-86.757-172.339-172.771-168.589
Other Financing Activities -0.001-1.06-1.06-3.234-0.001-3.201-3.201-3.202-1.06780000399.99901,599.999-0.001-0.002
Financing Cash Flow -104.986-1.615-1.62-3.829-44.37-266.799-270.509-437.279-315.994-314.405-239.235-199.625197.997-150.3291,409.986-187.329654.96
Other Information:
Effect Of Forex Changes On Cash 000.0010-0.001-0.002-0.0010.001-0.001000.0010.00100-0.0010.001
Net Change In Cash -214.678647.436388.127-39.904-378.147-586.764237.862682.94-50.831-409.339448.391,069.461282.153-120.466-754.832447.932-122.896
Cash At End Of Period 3,664.6473,879.3253,231.8892,843.7622,883.6663,261.8133,848.5773,610.7152,927.7752,978.6063,387.9452,939.5551,870.0941,587.9411,708.4072,463.2392,015.307